161 related articles for article (PubMed ID: 20868293)
21. Preclinical testing of new drugs for tuberculosis: current challenges.
Lenaerts AJ; Degroote MA; Orme IM
Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
23. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
[TBL] [Abstract][Full Text] [Related]
24. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
Reichlin S; Frei R; Reusser P
Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
[TBL] [Abstract][Full Text] [Related]
25. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
26. [Difficulties in the treatment of pulmonary tuberculosis in children].
Brînză N; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
[TBL] [Abstract][Full Text] [Related]
27. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
28. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
29. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
[TBL] [Abstract][Full Text] [Related]
31. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
[TBL] [Abstract][Full Text] [Related]
32. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of tuberculosis].
Dautzenberg B
Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
[TBL] [Abstract][Full Text] [Related]
34. Drug-resistant Mycobacterium tuberculosis in California, 1991 to 1992.
Koo D; Royce S; Rutherford GW
West J Med; 1995 Nov; 163(5):441-5. PubMed ID: 8533406
[TBL] [Abstract][Full Text] [Related]
35. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of tuberculosis].
Covi M; Velluti G
Medicina (Firenze); 1989; 9(4):355-74. PubMed ID: 2517449
[TBL] [Abstract][Full Text] [Related]
38. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
Zierski M
Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
[No Abstract] [Full Text] [Related]
39. [Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan].
Kibrik BS; Pavlov AV; Chelnokova OG
Eksp Klin Farmakol; 2013; 76(2):20-2. PubMed ID: 23631279
[TBL] [Abstract][Full Text] [Related]
40. Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.
Yimer SA; Agonafir M; Derese Y; Sani Y; Bjune GA; Holm-Hansen C
APMIS; 2012 Jun; 120(6):503-9. PubMed ID: 22583363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
